Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Here's an EXAMPLE of a helpful press release (compliments of edig)

"Would TPL attempting a hostile takeover be necessarily a bad thing?"

Pay me $2.25 per share to go away.

  With a pps in the lowly 60 cents range???The shareholders would unite in anarchy!

Share
New Message
Please login to post a reply